STOCK TITAN

Sotera Health Company (SHC) Stock News, Dec 2024-Jul 2025

SHC NASDAQ

Sotera Health Company provides sterilization solutions, lab testing and advisory services for the healthcare industry through Sterigenics, Nordion and Nelson Labs. News about SHC commonly covers quarterly and annual operating results, constant-currency revenue trends, Adjusted EBITDA commentary and outlook updates across those businesses.

Recurring company developments also include segment performance in outsourced terminal sterilization, irradiation services and laboratory testing, as well as governance changes, board committee assignments and capital-structure activity involving its Nasdaq-listed common stock. Sterigenics uses gamma irradiation, EO processing and E-beam irradiation for medical device, pharmaceutical, food safety and other application markets.

Rhea-AI Summary

Sotera Health (Nasdaq: SHC), a leading provider of sterilization solutions and lab testing services for the healthcare industry, has scheduled its second-quarter 2025 financial results release for August 8, 2025, before market open.

The company will host a conference call at 9:00 a.m. EDT to discuss results and operating highlights. Investors can participate via phone (US toll-free: 1-844-481-2916; International: 1-412-317-0709) or access the live webcast through the company's Investor Relations website. Conference materials will be available, and a webcast replay will be posted later that day.

[]
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.08%
Tags
-
Rhea-AI Summary
Sotera Health (SHC) reported mixed Q1 2025 financial results. Net revenues increased 2.6% to $255 million (4.4% on constant currency), while posting a net loss of $13 million ($0.05 per share) compared to net income of $6 million in Q1 2024. The loss includes a $31 million settlement related to ethylene oxide claims. Adjusted EBITDA grew 8.8% to $122 million. By segment: Sterigenics revenues rose 1.9%, Nordion increased 35.6%, while Nelson Labs declined 9.3%. The company maintains its 2025 outlook, projecting 4-6% revenue growth and 4.5-6.5% Adjusted EBITDA growth on constant currency. The balance sheet shows $2.3B in debt and $304M cash, with an improved Net Leverage Ratio of 3.6x.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.22%
Tags
-
Rhea-AI Summary

Sotera Health (Nasdaq: SHC), a leading global provider of sterilization solutions and lab testing services for the healthcare industry, has scheduled its first-quarter 2025 financial results release for Thursday, May 1, 2025, before market opening.

The company will host a conference call at 9:00 a.m. Eastern Daylight Time to discuss Q1 2025 results and operating highlights. Participants can join via phone (1-844-481-2916 US toll-free; 1-412-317-0709 international) or access the live webcast through the Investor Relations section of Sotera Health's website. Conference materials will be available, and a webcast replay will be accessible later that day.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.53%
Tags
Rhea-AI Summary

Nelson Labs, a Sotera Health company, has launched Rapid Sterility Testing services at three laboratory sites across the United States and Europe. This innovative testing method reduces product sterility test results time from the traditional 14-day period to as little as 6 days, while maintaining compliance with USP <71> and <1223> standards.

The new testing solution uniquely supports both medical device and pharmaceutical products, expanding beyond the typical focus on biological components or short shelf-life products. The method employs quantitative data instrumentation to automate test results, reducing human error potential. This advancement enables faster product release while maintaining quality and safety standards.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.80%
Tags
none
-
Rhea-AI Summary

Sotera Health (Nasdaq: SHC) reported its Q4 and full-year 2024 results, showing mixed performance. Full-year 2024 highlights include:

- Net revenues increased 4.9% to $1.10 billion
- Net income of $44 million ($0.16 per diluted share)
- Adjusted EBITDA grew 3.9% to $549 million

However, Q4 2024 showed some weakness:
- Net revenues decreased 6.5% to $290 million
- Net income dropped to $12 million ($0.04 per diluted share)
- Adjusted EBITDA declined 8.3% to $153 million

For 2025 outlook, the company projects:
- Net revenues growth of 4.0% - 6.0%
- Adjusted EBITDA growth of 4.5% - 6.5%
- Adjusted EPS range of $0.70 to $0.76

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.97%
Tags
-
Rhea-AI Summary

Sotera Health Company (Nasdaq: SHC), a leading global provider of sterilization solutions and lab testing services for the healthcare industry, has scheduled its fourth-quarter and full-year 2024 financial results release for Thursday, February 27, 2025, before market opening.

The company will host a conference call at 9:00 a.m. Eastern Time to discuss operating highlights and financial results. Participants can join by dialing 1-844-481-2916 (US) or 1-412-317-0709 (international locations). A live webcast and accompanying materials will be accessible through the company's Investor Relations website, with a replay available later that day.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.96%
Tags
Rhea-AI Summary

Sotera Health (Nasdaq: SHC) presented at the 43rd Annual J.P. Morgan Healthcare Conference, where Chairman and CEO Michael B. Petras, Jr. provided a business update. The company, a leading provider of sterilization solutions and lab testing services for the healthcare industry, expects to report full-year revenues of approximately $1.1 billion for 2024, representing nearly 5% growth compared to 2023 and over 5% growth on a constant currency basis.

The company's management team, including CFO Jon Lyons and VP of Investor Relations Jason Peterson, are participating in investor meetings during the conference. A live webcast of the presentation is available on the company's website, with a replay to be archived. Full 2024 financial results and 2025 outlook will be reported on February 27, 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.52%
Tags
none
-
Rhea-AI Summary

Sotera Health Company (NASDAQ: SHC), a leading global provider of sterilization solutions, lab testing, and healthcare advisory services, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. Chairman and CEO Michael B. Petras, Jr. will deliver a presentation on Tuesday, January 14, 2025, at 11:15 a.m. Eastern Time.

The company's senior leadership team, including CFO Jon Lyons and VP of Investor Relations Jason Peterson, will engage in investor meetings throughout the conference. Investors and interested parties can access a live webcast of the presentation through Sotera Health's Investor Relations website section under Presentations & Events. The presentation materials will be available for viewing, and a replay will be accessible within 48 hours after the conference concludes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.74%
Tags
conferences
-
Rhea-AI Summary

Sotera Health Company (Nasdaq: SHC) has appointed Vincent K. Petrella as Lead Independent Director, effective January 2, 2025. Petrella, who has been serving on the company's Board of Directors since 2020, will act as a key liaison among the Board, management, and shareholders.

The appointment leverages Petrella's decades of public company executive leadership and board experience, including his role as chairperson of Sotera Health's Audit Committee. Michael B. Petras, Jr., Sotera Health Chairman and CEO, highlighted Petrella's valuable experience, insight, and engagement since joining the Board.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.37%
Tags
management
Rhea-AI Summary

Firstlight Management LP, a shareholder of Sotera Health Company (SHC), has sent a letter to the Board of Directors urging the sale of its Nelson Labs subsidiary. The investment firm argues that Nelson Labs has underperformed with a mere 2.7% EBITDA CAGR over 2018-2024E, significantly lower than Sterigenics (9.8%) and Nordion (8.2%). The proposed sale could generate approximately $1.1bn in gross proceeds at a 15.2x EBITDA multiple, potentially reducing SHC's net leverage ratio from 3.7x to 2.2x on 2024E EBITDA. The transaction could result in ~13% lift to 2025E EPS and allow management to focus on core sterilization businesses.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.92%
Tags
none

FAQ

What is the current stock price of Sotera Health (SHC)?

Sotera Health (SHC) last closed at $16.61.

What is the market cap of Sotera Health (SHC)?

The market cap of Sotera Health (SHC) is approximately $4.7B.